Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma

S. Mannisto; P. Vähämurto; M. Pollari; M.R. Clausen; S. Jyrkkiö; P.-L. Kellokumpu-Lehtinen; P. Kovanen; M.-L. Karjalainen-Lindsberg; F. d'Amore; S. Leppä

doi:10.1016/j.ejca.2019.04.004

Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma

S. Mannisto
, P. Vähämurto
, M. Pollari
, M.R. Clausen
, S. Jyrkkiö
, P.-L. Kellokumpu-Lehtinen
, P. Kovanen
, M.-L. Karjalainen-Lindsberg
, F. d'Amore
, S. Leppä

Research output: Contribution to journal › Article › Scientific › peer-review

22 Citations (Scopus)

Original language	English
Pages (from-to)	27-36
Journal	European Journal of Cancer
Volume	115
DOIs	https://doi.org/10.1016/j.ejca.2019.04.004
Publication status	Published - 2019
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

CNS-directed therapy
Primary testicular lymphoma
Prophylactic testicular irradiation
Rituximab
Survival

Publication forum classification

Publication forum level 2

Access to Document

10.1016/j.ejca.2019.04.004

Cite this

Mannisto, S., Vähämurto, P., Pollari, M., Clausen, M. R., Jyrkkiö, S., Kellokumpu-Lehtinen, P.-L., Kovanen, P., Karjalainen-Lindsberg, M.-L., d'Amore, F., & Leppä, S. (2019). Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma. European Journal of Cancer, 115, 27-36. https://doi.org/10.1016/j.ejca.2019.04.004

@article{3ee3a3a8212845a7b4e622305319b7a6,

title = "Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma",

keywords = "CNS-directed therapy, Primary testicular lymphoma, Prophylactic testicular irradiation, Rituximab, Survival, CNS-directed therapy, Primary testicular lymphoma, Prophylactic testicular irradiation, Rituximab, Survival",

author = "S. Mannisto and P. V{\"a}h{\"a}murto and M. Pollari and M.R. Clausen and S. Jyrkki{\"o} and P.-L. Kellokumpu-Lehtinen and P. Kovanen and M.-L. Karjalainen-Lindsberg and F. d'Amore and S. Lepp{\"a}",

year = "2019",

doi = "10.1016/j.ejca.2019.04.004",

language = "English",

volume = "115",

pages = "27--36",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier",

}

Mannisto, S, Vähämurto, P, Pollari, M, Clausen, MR, Jyrkkiö, S, Kellokumpu-Lehtinen, P-L, Kovanen, P, Karjalainen-Lindsberg, M-L, d'Amore, F & Leppä, S 2019, 'Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma', European Journal of Cancer, vol. 115, pp. 27-36. https://doi.org/10.1016/j.ejca.2019.04.004

TY - JOUR

T1 - Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma

AU - Mannisto, S.

AU - Vähämurto, P.

AU - Pollari, M.

AU - Clausen, M.R.

AU - Jyrkkiö, S.

AU - Kellokumpu-Lehtinen, P.-L.

AU - Kovanen, P.

AU - Karjalainen-Lindsberg, M.-L.

AU - d'Amore, F.

AU - Leppä, S.

PY - 2019

Y1 - 2019

KW - CNS-directed therapy

KW - Primary testicular lymphoma

KW - Prophylactic testicular irradiation

KW - Rituximab

KW - Survival

KW - CNS-directed therapy

KW - Primary testicular lymphoma

KW - Prophylactic testicular irradiation

KW - Rituximab

KW - Survival

U2 - 10.1016/j.ejca.2019.04.004

DO - 10.1016/j.ejca.2019.04.004

M3 - Article

SN - 0959-8049

VL - 115

SP - 27

EP - 36

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -